US biotech TRIO Pharmaceuticals has announced the appointment of Patrick Doyle as chief executive (CEO effective immediately.

Scottish biotech Trogenix has announced two senior appointments as the company advances its pipeline towards the clinic.

The market for selective estrogen receptor modulators, or SERMs, is poised for considerable growth over the next decade, ...

The European Medicines Agency has called for updated rules and processes to reflect growing use of artificial intelligence in ...

The Institute for Clinical and Economic Review (ICER) has cast doubt on the value of a new spinal muscular atrophy treatment ...

US precision immune-oncology firm I-Mab has entered into a definitive agreement to acquire 100% ownership of Bridge Health ...

Japanese drug major Astellas Pharma has signed a memorandum of understanding with the Korea Institute of Startup and ...

Behind the Numbers 2026 report, outlining the primary inflators and deflators of healthcare costs across the industry. It ...

A major collaboration between the Allen Institute and the Aligning Science Across Parkinson’s (ASAP) initiative is set to ...

French biotech One Biosciences has raised 15 million euros ($16 million) in series A financing to advance development of its ...

French ophthalmology company Nicox (EPA: ALCOX) has signed an agreement with Japan’s Kowa Company (TYO: 7807).

The US Food and Drug Administration (FDA) announced the approval of 127 innovator and biosimilar drugs in 2024, a notable ...